Extracellular Vesicle-Based Antitumor Nanomedicines

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Extracellular vesicles (EVs) are natural nanocarriers with therapeutic potential.
• Existing reviews lack comprehensive coverage of EV-based nanomedicines for cancer therapy.

Purpose of the Study:

• To review the potential of EVs as antitumor nanomedicines.
• To systematically examine methods for EV extraction, drug loading, and engineering.
• To discuss clinical translation challenges and opportunities.

Main Methods:

• Systematic examination of EV extraction techniques.
• Assessment of various drug-loading strategies for EVs.
• Analysis of engineering modifications for enhanced therapeutic efficacy.
• Review of clinical translation hurdles and future prospects.

Main Results:

• EVs offer excellent stability and biocompatibility for drug delivery.
• Multiple methods exist for EV extraction, drug loading, and modification, each with specific strengths and limitations.
• Key strategies for developing EV-based antitumor therapies are identified.

Conclusions:

• EVs hold significant promise as a platform for developing novel antitumor nanomedicines.
• Further interdisciplinary research is needed to overcome challenges in clinical translation.
• Robust EV-based therapeutic platforms can lead to personalized cancer treatments.